AIBT vs GLUC: stock comparison and AI forecast
Aibotics, Inc. (AIBT) and Glucose Health, Inc. (GLUC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AIBT Aibotics, Inc.
- Market Cap
- $3M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
GLUC Glucose Health, Inc.
- Price
- $0.32 +3.2% · 6M
- Market Cap
- $9M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GLUC is 2.6 times larger than AIBT by market capitalization ($9M against $3M).
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AIBT | GLUC |
|---|---|---|
| Market Cap | $3M | $9M |
Profitability & Margins
| Metric | AIBT | GLUC |
|---|---|---|
| ROA | -366.6% | – |
| ROIC | 35.1% | – |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | AIBT | GLUC |
|---|---|---|
| Current Ratio | 0.05x | – |
| Quick Ratio | 0.05x | – |
| Interest Coverage | -8.8x | 0.8x |
| Working Capital | -$5M | – |
Cash Flow
| Metric | AIBT | GLUC |
|---|---|---|
| Operating Cash Flow | -$490K | -$20K |
Operational Efficiency
| Metric | AIBT | GLUC |
|---|---|---|
| Inventory Turnover | 0.0x | – |
Income Statement
| Metric | AIBT | GLUC |
|---|---|---|
| Operating Income | -$2M | -$40K |
| Net Income | -$2M | – |
| Cost of Goods Sold | $0.00M | $30K |
Dividend & Shareholder Information
| Metric | AIBT | GLUC |
|---|---|---|
| Shares Outstanding | 850M | 27M |
AIBT vs GLUC: stock comparison and AI forecast
Which is bigger, AIBT or GLUC?
GLUC is 2.6 times larger than AIBT by market capitalization ($9M against $3M).
Which one does Intratio's AI model rank higher, AIBT or GLUC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.